Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jia Luo, M.D.

Concepts (117)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jia Luo's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jia Luo has written about over time.
Mind-Body Therapies, 1 publications between 2014 and 2014, average publication date May 2014. Spiritual Therapies, 1 publications between 2014 and 2014, average publication date May 2014. Coronavirus, 1 publications between 2020 and 2020, average publication date May 2020. Coronavirus Infections, 2 publications between 2020 and 2020, average publication date May 2020. Pneumonia, Viral, 2 publications between 2020 and 2020, average publication date May 2020. Pyridones, 1 publications between 2021 and 2021, average publication date January 2021. Pyrimidinones, 1 publications between 2021 and 2021, average publication date January 2021. Thyroid Diseases, 1 publications between 2021 and 2021, average publication date July 2021. Lung Neoplasms, 20 publications between 2016 and 2023, average publication date August 2021. Carcinoma, Non-Small-Cell Lung, 9 publications between 2020 and 2023, average publication date December 2021. Pneumothorax, 1 publications between 2022 and 2022, average publication date September 2022. Thoracic Neoplasms, 1 publications between 2022 and 2022, average publication date September 2022. Proto-Oncogene Proteins p21(ras), 4 publications between 2022 and 2023, average publication date January 2023.

To see the data from this visualization as text, click here.
Luo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.